PUBLIC COMPANY
saveINDIVIOR
USupdated 3d ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Supernus and Indivior merge to create CNS mega-company with 11 approved drugsSupernus Pharmaceuticals and Indivior Pharmaceuticals are outlining a combined expected $2.2 billion in annual revenue, plus $125 million in cost savings that will include “natural redundancies.”biospace · 3h ago
- Update: Supernus, Indivior to merge and form CNS-focused drugmakerSupernus and Indivior have signed an all-stock merger agreement to establish a new company that they believe could be a leader in central nervous system disease. The combined company, which will be…endpoints · 5h ago
comments(0)
5-min edit window · permanent after that